Hôpitaux Universitaires Henri Mondor

Créteil 94010

1 studies enrolling now · 3 studies all time

What they study most

Refractory Hodgkin Lymphoma, Relapsed Hodgkin Lymphoma, Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Studies at this site

• An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) — Enrolling by invitation
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed